Microarray analysis of tonsils in immunoglobulin A nephropathy patients.

[1]  H. Rakugi,et al.  A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN). , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  K. Kitamura,et al.  Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[3]  M. Takahara,et al.  Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. , 2008, Clinical immunology.

[4]  M. Klein,et al.  The APOBEC-2 crystal structure and functional implications for the deaminase AID , 2007, Nature.

[5]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[6]  G. Appel,et al.  The IgA nephropathy treatment dilemma. , 2006, Kidney international.

[7]  Tsutomu Chiba,et al.  Expression of APOBEC2 is transcriptionally regulated by NF‐κB in human hepatocytes , 2006, FEBS letters.

[8]  M. Neuberger,et al.  Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. , 2005, Molecular biology and evolution.

[9]  I. Narita,et al.  Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. , 2004, Kidney international.

[10]  I. Narita,et al.  The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. , 2003, Kidney international.

[11]  Y. Taguma,et al.  Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  E. Pettersson.  IgA nephropathy: 30 years on , 1997, Journal of internal medicine.

[13]  M. Béné,et al.  Enhanced expression of CD31 and CD54 on tonsillar high endothelial venules in IgA nephropathy. , 1997, Clinical immunology and immunopathology.

[14]  Masaki Kobayashi,et al.  Natural history and risk factors for immunoglobulin a nephropathy in Japan , 1997 .

[15]  M. Béné,et al.  Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. , 1983, The Journal of clinical investigation.

[16]  S. Nakai,et al.  A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report. , 2007, Contributions to nephrology.

[17]  M. Kawaguti.  Expanded primary T nodules in the palatine tonsils from patients with IgA nephropathy , 1993 .

[18]  Y. Masuda,et al.  Expanded primary T nodules in the palatine tonsils from patients with IgA nephropathy. , 1993, Acta oto-laryngologica. Supplementum.

[19]  Clinique Nephrologique.  QUANTITATIVE IMMUNOHISTOMORPHOMETRY OF THE TONSILLAR PLASMA CELLS EVIDENCES AN INVERSION OF THE IMMUNOGLOBULIN A VERSUS IMMUNOGLOBULIN G SECRETING CELL BALANCE , 1983 .